跳至主要内容
临床试验/NCT01303614
NCT01303614Unknown4 期

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice: a Prospective Randomized Double Blind, Placebo-controlled Clinical Trial

Consorci Sanitari de Terrassa1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
100
试验地点
1
主要终点
pain reduction in the performance of hysterosalpingography

研究概览

简要总结

The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysterosalpingography diagnostic practice.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • patients that must perform a hysterosalpingography
  • acceptance to participate in the study signed informed consent

排除标准

  • hypersensitivity or allergy to anesthetics
  • refusal of the patient
  • patients under age 18 years old and pregnant
  • unbearable pain that involves other analgesic measures

研究组 & 干预措施

Lidocaine-Prilocaine cream

Active Comparator

干预措施: Lidocaine-Prilocaine cream (Drug)

Placebo

Placebo Comparator

purified water, ethylene glycol stearate, palm, palm stearate, polyethylene glycol, liquid paraffin, benzoic acid

干预措施: placebo (Drug)

结局指标

主要结局

pain reduction in the performance of hysterosalpingography

时间窗: after hysterosalpingography and a month later

decrease in pain inmediately after the completion of hysterosalpingography and one month after completion of the diagnostic test by an analogue pain scale.

次要结局

  • sense of discomfort experience during the procedure(a month after hysterosalpingography)

研究者

发起方
Consorci Sanitari de Terrassa
申办方类型
Other

研究点 (1)

Loading locations...

相似试验